Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Medicare developed a program to rein in the costs of cancer treatment, but the results were disappointing, a new study reveals, with this comprehensive approach reducing costs by about 1%. William Nelson, director of the Kimmel Cancer Center at Johns …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about …
Do we really need a new monoclonal antibody for Covid-19? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Monoclonal antibodies remain a treatment option for those in early stages of Covid infection, even in the face of new oral medications that likely will be available soon. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says the …
Podcast: Download (Duration: 1:07 — 1.6MB)
Subscribe: RSS
Both Pfizer and Merck have recently revealed promising data on oral medicines for early Covid-19 infection, with both companies on the threshold of widespread use of the drugs. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says he …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Pfizer has asked the FDA to approve its new oral medication for Covid-19, called Paxlovid, for people in the early stages of infection. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, reviews the data. Garibaldi: From symptom onset …
Podcast: Download (Duration: 1:06 — 1.5MB)
Subscribe: RSS
More expensive analog insulins are used by the majority of people with diabetes who use insulin, a study by Rita Kalyani, a diabetes expert at Johns Hopkins, and colleagues has shown. Is this practice based in any professional society recommendations? …
